1 results match your criteria: "and the Oncology Center of Excellence (M.R.T.[Affiliation]"
The Drug-Dosing Conundrum in Oncology - When Less Is More.
N Engl J Med
October 2021
From the Office of Oncologic Diseases (M.S.) and the Division of Cancer Pharmacology II, Office of Clinical Pharmacology (A.R.), Center for Drug Evaluation and Research, and the Oncology Center of Excellence (M.R.T., R.P.), Food and Drug Administration, Silver Spring, MD.